CoChat

The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis

Open access
Kobayashi, Hiroki, Gieniec, Krystyna A., Wright, Josephine A., Wang, Tongtong, Asai, Naoya, Mizutani, Yasuyuki, Lida, Tadashi, Ando, Ryota, Suzuki, Nobumi, Lannagan, Tamsin R.M., Ng, Jia Q., Hara, Akitoshi, Shiraki, Yukihiro, Mii, Shinji, Ichinose, Mari, Vrbanac, Laura, Lawrence, Matthew J., Sammour, Tarik, Uehara, Kay, Davies, Gareth, Lisowski, Leszek, Alexander, Ian E., Hayakawa, Yoku, Butler, Lisa M., Zannettino, Andrew C.W., Din, M. Omar, Hasty, Jeff, Burt, Alastair D., Leedham, Simon J., Rustgi, Anil K., Mukherjee, Siddhartha, Wang, Timothy C., Enomoto, Atsushi, Takahashi, Masahide, Worthley, Daniel L., Woods, Susan L. · 2021 · Gastroenterology
Cited by 156

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background & AIMS Cancer-associated fibroblasts (CAFs), key constituents of the tumor microenvironment, either promote or restrain tumor growth. Attempts to therapeutically target CAFs have been hampered by our incomplete understanding of these functionally heterogeneous cells. Key growth factors in the intestinal epithelial niche, bone morphogenetic proteins (BMPs), also play a critical role in colorectal cancer (CRC) progression. However, the crucial proteins regulating stromal BMP balance and the potential application of BMP signaling to manage CRC remain largely unexplored. Methods Using human CRC RNA expression data, we identified CAF-specific factors involved in BMP signaling, then verified and characterized their expression in the CRC stroma by in situ hybridization. CRC tumoroids and a mouse model of CRC hepatic metastasis were used to test approaches to modify BMP signaling and treat CRC. Results We identified Grem1 and Islr as CAF-specific genes involved in BMP signaling. Functionally, GREM1 and ISLR acted to inhibit and promote BMP signaling, respectively. Grem1 and Islr marked distinct fibroblast subpopulations and were differentially regulated by transforming growth factor β and FOXL1, providing an underlying mechanism to explain fibroblast biological dichotomy. In patients with CRC, high GREM1 and ISLR expression levels were associated with poor and favorable survival, respectively. A GREM1-neutralizing antibody or fibroblast Islr overexpression reduced CRC tumoroid growth and promoted Lgr5+ intestinal stem cell differentiation. Finally, adeno-associated virus 8 (AAV8)–mediated delivery of Islr to hepatocytes increased BMP signaling and improved survival in our mouse model of hepatic metastasis. Conclusions Stromal BMP signaling predicts and modifies CRC progression and survival, and it can be therapeutically targeted by novel AAV-directed gene delivery to the liver.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2020.11.011

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 156

Metadata

Authors
Kobayashi, H., Gieniec, K. A., Wright, J. A., Wang, T., Asai, N., Mizutani, Y., Lida, T., Ando, R., Suzuki, N., Lannagan, T. R. M., Ng, J. Q., Hara, A., Shiraki, Y., Mii, S., Ichinose, M., Vrbanac, L., Lawrence, M. J., Sammour, T., Uehara, K., Davies, G., Lisowski, L., Alexander, I. E., Hayakawa, Y., Butler, L. M., Zannettino, A. C. W., Din, M. O., Hasty, J., Burt, A. D., Leedham, S. J., Rustgi, A. K., Mukherjee, S., Wang, T. C., Enomoto, A., Takahashi, M., Worthley, D. L., & Woods, S. L.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2021-03
Volume
160
Issue
4
Pages
1224-1239.e30
ISSN
0016-5085 (ISSN-L)
OpenAlex
W3103125459
Cited by
156
References
7
FWCI
4.98
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.